Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).
Clinical trial NCT02525874 · COMPLETED
Trial details
- NCT number
- NCT02525874
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-11
- Primary completion
- 2017-04-24
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.